
News|Articles|December 9, 2003
ALLHAT and JNC 7: Health-system applications and economic considerations
New Orleans-The results of the Antihypertensive and Lipid-Lowering Treatmentto Prevent Heart Attack (ALLHAT) Trial, along with the highlights of theSeventh Report of the Joint National Committee on Prevention, Detection,Evaluation, and Treatment of High Blood Pressure (JNC 7), were presentedon Dec. 9 at an educational session of the 38th ASHP Midyear Clinical Meeting.
Advertisement
Advertisement
Advertisement
Advertisement
Trending on Managed Healthcare Executive
1
ALK Testing Strategies and Navigating First-Line Treatment Options in Advanced NSCLC
2
How PBMs are tackling behavioral health
3
ALK-Positive NSCLC: Epidemiology, Prognosis, and the Critical Role of Biomarker Testing
4
Most commercial plans cover SC and IV oncology therapies at parity
5































